Welcome - Home - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Kosan Biosciences' returned 60 results - Page 2 of 3   Sort by    Report Name ASC Report Name DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Companion Diagnostics: Enabling Personalized Medicines in Cancer   Decision Resources, Inc., Oct 2006, Pages: 30 ... Enlight Biosciences - Exelixis - Genentech - GlaxoSmithKline - GlycoFi - Johnson & Johnson - KAI Pharmaceuticals - Kosan Biosciences - Medarex - MedImmune ... Roche - Pipeline - Products - Performance - Potential   Espicom Business Intelligence Ltd, June 2009, Pages: 266 ... Division - Iceland Genomics - International Genomics Consortium - Johnson & Johnson Pharmaceutical - Research & Development - Kosan Biosciences epothilone D (R ... Cancer Therapies - Global Market Opportunities   Bizacumen Inc., Nov 2009, Pages: 486 ... SA - ImmunoGen Inc - Inotek Pharmaceuticals Corporation - InterMune Inc - Isotechnika Inc - Japan Tobacco Inc (JT)/Pfizer - Kosan Biosciences - Lonza Biologics ... Target Analytical Report - ABL1   Jubilant Biosys Limited, Sep 2008, Pages: 158 ... Partnership Agreement with Amgen 42 Genentech and Roche Ink a Licensing Agreement with Glycart 43 Bristol-Myers Squibb to Acquire Kosan Biosciences 43 Nabi ... Who's Developing What in New Cancer Drugs 2007?   Espicom Business Intelligence Ltd, Nov 2007, Pages: 1500 ... Kosan Biosciences Inc. - Kylix Pharmaceuticals - Kyowa Hakko Kogyo Co - Locus Pharmaceuticals Inc. - Medvet Science Pty Ltd. - Merck & Co. Inc. ... Lung Cancer Therapeutics - Global Strategic Business Report   Global Industry Analysts, Inc., July 2009, Pages: 842 ... Immunomedics - INEX Pharmaceuticals - Introgen Therapeutics - Isis Pharmaceuticals - Keryx Biopharmaceuticals - Kirin Brewery - Kosan Biosciences - Kyowa Hakko ... Currently Druggable in Breast Cancer: A Drug Target Competitive Analysis   Bioseeker, Aug 2008, Pages: 316 ... Acquires U3 Pharma II-38 MacroGenics Takes Over Raven Biotechnologies II-38 Roche Acquires Piramed II-38 Bristol-Myers Squibb Acquires Kosan Biosciences II-39 ... Change Is Percolating Through Japan's Pharmaceutical Markets   Decision Resources, Inc., Sep 2007, Pages: 37 ... Innovive - Inovio - Insmed - Introgen Therapeutics - Ipsen - Isis Pharmaceuticals - Johnson & Johnson - Karus Therapeutics - Kosan Biosciences - Kyowa Hakko ... Cancer Breast Cancer   Life Science Analytics, March 2008, Pages: 395 ... Pharma -Janssen -Janssen Kyowa -Janssen-Cilag -Johnson & Johnson -Kaken Pharmaceutical -Kirin Brewery -Kirin-Amgen -Kissei -Kosan Biosciences -Kyorin -Kyowa ... Digestive System - Gastroesophageal Reflux Disease Drug Pipeline Report   Life Science Analytics, June 2007, Pages: 13 ... Inc --Epeius Biotechnologies Corporation --GlaxoSmithKline plc --Genzyme Corporation --Johnson & Johnson --Ipsen Ltd --Kosan Biosciences Incorporated --Keryx ... Bristol-Myers Squibb Co.: PharmaVitae Profile   Datamonitor, Sep 2009, Pages: 120 ... Kosan Biosciences Incorporated --MOVETIS NV --NPS Pharmaceuticals Inc --Pfizer Inc Pipeline Revenue --Pipeline Revenue Full Pipeline View --Pre Clinical ... Digestive System Gastroesophageal Reflux Disease   Life Science Analytics, March 2008, Pages: 123 ... Key findings Background Key corporate developments Bristol-Myers Squibb Bristol-Myers Squibb M&A history Medarex Kosan Biosciences Adnexus Therapeutics ... Breast Cancer Drug Pipeline Report   Life Science Analytics, June 2007, Pages: 39 ... Kosan Biosciences Incorporated --MOVETIS NV --Pfizer Inc --Takeda Pharmaceutical Company Limited Pipeline Revenue --Pipeline Revenue Full Pipeline View --Pre ... Evolving Trends in Licensing: Strategies for Building and Retaining Value in Biotechnology Alliances   Decision Resources, Inc., Aug 2008, Pages: 33 ... Inc --Epeius Biotechnologies Corp --GlaxoSmithKline plc --Genzyme Corporation --Johnson & Johnson --Ipsen Ltd --Kosan Biosciences Incorporated --Keryx ... Prostate and Breast Cancer- New Treatments & Developmental Progress   Bioseeker, March 2007, Pages: 192 ... GlycoFi - Icagen - Ilypsa - Infinity Pharmaceuticals - Isis Pharmaceuticals - Janssen Pharmaceutica - Johnson & Johnson - Kosan Biosciences - Kyowa Hakko ... SPECIAL REPORT: Lessons Learned in the Pharma Industry, 2008   Decision Resources, Inc., Dec 2008, Pages: 65 ... Eli Lilly, Encore Pharmaceuticals, Genentech, GlaxoSmithKline, Genta, GTx, Isis Pharmaceuticals, Johnson and Johnson, Kosan Biosciences, Lorus Therapeutics ... Synthetic Biology, A New Paradigm For Biological Discovery   Beachhead Consulting, Feb 2006, Pages: 158 ... Cilag - Jerini - JHP Pharmaceuticals - John Ansell Consultancy - Johnson & Johnson - Kaiser Family Foundation - Kosan Biosciences - Laboratoires Roussel ... Small Molecule Kinase Inhibitors - Global Strategic Business Report   Global Industry Analysts, Inc., July 2009, Pages: 558 ... for the Assembly of New Polyketide Synthases Figure 5-3. The Process of Chemo-biosynthesis Technology used by Kosan Biosciences Figure 5-4. Heterologous ... Innovative Targeted Therapies - Smart Drugs On Target For Increasing Growth   Datamonitor, Oct 2005, Pages: 348 ... Commercialize PLX5568 II-50 OSI Applies Additional NDA for Tarceva II-50 KAI and BMS Forms Global Alliance on KAI-9803 II-51 Kosan Biosciences Commences Phase ... Prostate Cancer - A Therapeutic & Competitive Insight   Bioseeker, Jan 2007, Pages: 99 ... profile 170 Clinical trial data 171 Comments 172 Novartis?s AMN-107 173 Drug profile 173 Clinical trial data 174 Comments 174 Kosan Biosciences? 17-AAG 175 ... Results:  First -   Prev -   1 -   2 -   3 -   Next -   Last

		Top of page

All rights reserved. © Copyright 2009 Research and Markets1    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster